Steven Bojarski, MD
Neurology · Wilmington, DENPI 1760412852
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 62 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$252
- Eisai Inc.$151
- AbbVie$142
- Genentech USA, Inc.$114
- Pfizer$71
- Jazz Pharmaceuticals Inc.$55
- plus $442 from 17 others
What the payments were for
- Food & beverage$1,227100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 13 | $252 |
| Eisai Inc. | 7 | $151 |
| AbbVie | 8 | $142 |
| Genentech USA, Inc. | 1 | $114 |
| Pfizer | 4 | $71 |
| Jazz Pharmaceuticals Inc. | 4 | $55 |
| Lundbeck LLC | 3 | $49 |
| Sunovion Pharmaceuticals Inc. | 4 | $47 |
| Tactile Systems Technology Inc | 1 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Argenx US, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
| Amgen | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Orthogenrx Inc. | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Neurelis, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$1,227 in reported general payments places this provider in the 65th percentile of 61 neurology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 14 | $287,978 |
| OxycontinOxycodone Hcl | 16 | $30,027 |
| Gabapentin | 139 | $2,796 |
| Oxycodone Hcl | 39 | $1,264 |
| Lidocaine | 16 | $1,184 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,066 |
| Divalproex Sodium | 39 | $951 |
| Methadone Hcl | 30 | $784 |
| Primidone | 26 | $725 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 44 | $668 |
| Baclofen | 19 | $585 |
| Pregabalin | 32 | $517 |
| Cyclobenzaprine Hcl | 48 | $505 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $435 |
| Alprazolam | 72 | $418 |
Paid to pharmacies, not to this prescriber.
Other neurology in Wilmington
- Andrew MowerWilmington$1K
- Kishor PatilWilmington$288
- P Trent RyanWilmington$19
- Justin MartelloNewark$485K
- Abraham ScheerDover$231K
- Jason SilversteenNewark$202K
- Jay DaveMilford$161K
- Lawrence KempLewes$24K
- Etsegenet TizazuNewark$15K
- William SommersNewark$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.